4-38831586-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006068.5(TLR6):​c.-64-2049G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.562 in 151,944 control chromosomes in the GnomAD database, including 24,561 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.56 ( 24561 hom., cov: 32)

Consequence

TLR6
NM_006068.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0740

Publications

14 publications found
Variant links:
Genes affected
TLR6 (HGNC:16711): (toll like receptor 6) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor functionally interacts with toll-like receptor 2 to mediate cellular response to bacterial lipoproteins. A Ser249Pro polymorphism in the extracellular domain of the encoded protein may be associated with an increased of asthma is some populations.[provided by RefSeq, Jan 2011]
TLR1 (HGNC:11847): (toll like receptor 1) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This gene is ubiquitously expressed, and at higher levels than other TLR genes. Different length transcripts presumably resulting from use of alternative polyadenylation site, and/or from alternative splicing, have been noted for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.709 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TLR6NM_006068.5 linkc.-64-2049G>C intron_variant Intron 1 of 1 ENST00000508254.6 NP_006059.2 Q9Y2C9-1B2R933

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TLR6ENST00000508254.6 linkc.-64-2049G>C intron_variant Intron 1 of 1 1 NM_006068.5 ENSP00000424718.2 Q9Y2C9-1D6RAV7
TLR6ENST00000381950.2 linkc.-64-2049G>C intron_variant Intron 2 of 2 6 ENSP00000371376.1 Q9Y2C9-1
TLR1ENST00000506146.5 linkc.-353+25175G>C intron_variant Intron 1 of 5 4 ENSP00000423725.1 D6RCE8

Frequencies

GnomAD3 genomes
AF:
0.562
AC:
85275
AN:
151828
Hom.:
24539
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.675
Gnomad AMI
AF:
0.486
Gnomad AMR
AF:
0.501
Gnomad ASJ
AF:
0.633
Gnomad EAS
AF:
0.729
Gnomad SAS
AF:
0.573
Gnomad FIN
AF:
0.461
Gnomad MID
AF:
0.718
Gnomad NFE
AF:
0.504
Gnomad OTH
AF:
0.585
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.562
AC:
85347
AN:
151944
Hom.:
24561
Cov.:
32
AF XY:
0.560
AC XY:
41559
AN XY:
74258
show subpopulations
African (AFR)
AF:
0.675
AC:
27980
AN:
41466
American (AMR)
AF:
0.501
AC:
7651
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.633
AC:
2196
AN:
3470
East Asian (EAS)
AF:
0.729
AC:
3777
AN:
5182
South Asian (SAS)
AF:
0.574
AC:
2763
AN:
4814
European-Finnish (FIN)
AF:
0.461
AC:
4851
AN:
10518
Middle Eastern (MID)
AF:
0.707
AC:
208
AN:
294
European-Non Finnish (NFE)
AF:
0.504
AC:
34245
AN:
67912
Other (OTH)
AF:
0.586
AC:
1235
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1898
3796
5695
7593
9491
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
740
1480
2220
2960
3700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.407
Hom.:
1077
Bravo
AF:
0.568
Asia WGS
AF:
0.655
AC:
2274
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.47
DANN
Benign
0.28
PhyloP100
0.074
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5743788; hg19: chr4-38833207; API